NEW YORK -- Skinceuticals, a medical aesthetics skincare brand, is introducing the next generation of C E Ferulic. The dermatologist-recommended vitamin C serum supports skin longevity and delivers visible results.
"When the original C E Ferulic patent expired in 2025, we saw an opportunity to challenge ourselves—not because the formula needed to be reinvented, but because we wanted to ensure we were continuing to deliver the very best antioxidant serum on the market," said Tara Pyle, General Manager of SkinCeuticals USA. "We made the deliberate decision to preserve nearly the entire formula. There is continuity with the original formula physicians and consumers know and love, now enhanced to support all three dimensions of skin longevity—successfully extending the visible benefits of healthier, younger-looking skin— through our exclusive double patent-pending technology."
Skincare innovation is becoming more focused on preserving the skin's health, resilience and function over time. Skinceuticals built upon more than two decades of antioxidant research to evolve the C E Ferulic formula, selecting two new ingredients to further target the three dimensions of skin aging. The two new ingredients Camosine and Endophytol stimulate the skin's internal antioxidants and help protect cellular proteostasis and shield the skin from pollution-induced oxidative stress.
"C E Ferulic has been my go-to recommendation for patients because no other vitamin C serum has the same depth of scientific validation," said Board-Certified Dermatologist Patti Farris. "The original formula's stability prevents oxidation, its low pH allows optimal skin absorption, and the combination of actives promotes visibly meaningful improvements in wrinkles, discoloration, skin quality, and protection against environmental damage. This next-generation formula builds on that proven foundation, extending C E Ferulic's ability to support skin longevity while preserving everything that has made it the gold standard."
